ASTRO 2025 concludes! Thank you to our attendees, presenters and exhibitors for making ASTRO 2025 a spectacular success! Read highlights from Cancer Breakthroughs, expert commentary, and see recently published Annual Meeting-related articles in ASTRO journals and more!
While dMMR has been established as a key biomarker for a positive response to checkpoint inhibitors, the role of these drugs in the more common pMMR population has been unclear. By Avinash Chaurasia, MD, Brooke Army Medical Center
This study evaluated an automated QA method for CTV contouring in the TROG 08.08 TOPGEAR gastric cancer trial, aiming to reduce the resource burden of manual QA. By Jackie Wu, PhD, Duke University Medical Center
